New allergy spray tested in first human safety trial
NCT ID NCT07345442
Summary
This early-stage study tested the safety and how the body processes a new nasal spray called PA9159, intended for treating allergic rhinitis (hay fever). It involved 36 healthy Chinese adults who received either the spray or a placebo for one day or seven days. The main goal was to check for side effects and see how the drug moves through the body at different dose levels.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALLERGIC RHINITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The First Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, China
Conditions
Explore the condition pages connected to this study.